Responder analysis of the effects of denosumab on bone mineral density in men receiving androgen deprivation therapy for prostate cancer

被引：0
|
作者：
R B Egerdie
F Saad
M R Smith
T L J Tammela
J Heracek
P Sieber
C Ke
B Leder
R Dansey
C Goessl
机构：
[1] Urology Associates Urologic Medical Research,Département de Chirurgie
[2] Centre Hospitalier de l’Université de Montréal,Departments of Hematology/Oncology and Medicine
[3] Massachusetts General Hospital Cancer Center,Department of Urology
[4] Tampere University Hospital,undefined
[5] Androgeos,undefined
[6] Urological Associates of Lancaster,undefined
[7] Amgen,undefined
[8] Massachusetts General Hospital Endocrine Unit,undefined
来源：
Prostate Cancer and Prostatic Diseases | 2012年 / 15卷
关键词：
androgen deprivation; bone mineral density; bone loss; antiresorptive therapy; responder analysis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：308 / 312
页数：4
相关论文
共 50 条
  • [41] Androgen deprivation therapy in patients with prostate cancer and changes in bone mineral density.
    Alferos, MG
    Yaturu, S
    JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 : S243 - S243
  • [42] Changes in bone mineral density in patients with prostate cancer treated with androgen deprivation therapy
    Bernat, MM
    Pasini, J
    Marekovic, Z
    COLLEGIUM ANTROPOLOGICUM, 2005, 29 (02) : 589 - 591
  • [43] Bone mineral density testing after initiation of androgen deprivation therapy for prostate cancer
    Hu, Jason
    Dragomir, Alice
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 521 - 521
  • [44] Evaluation of bone turnover/quality markers and bone mineral density (BMD) in prostate cancer patients treated by androgen deprivation therapy with or without denosumab
    Miyazawa, Y.
    Syuto, T.
    Sekine, Y.
    Nomura, M.
    Koike, H.
    Matsui, H.
    Shibata, Y.
    Ito, K.
    Suzuki, K.
    INTERNATIONAL JOURNAL OF UROLOGY, 2017, 24 : 104 - 104
  • [45] Risk Factors for Bone Loss with Prostate Cancer in Korean Men Not Receiving Androgen Deprivation Therapy
    Kim, Sun-Ouck
    Kang, Taek Won
    Kwon, Dongdeuk
    Park, Kwangsung
    Ryu, Soo Bang
    INTERNATIONAL BRAZ J UROL, 2009, 35 (02): : 183 - 188
  • [46] Managing bone loss in men with locally advanced prostate cancer receiving androgen deprivation therapy
    Israeli, Ron S.
    Ryan, Christopher W.
    Jung, Laura L.
    JOURNAL OF UROLOGY, 2008, 179 (02): : 414 - 423
  • [47] NATURAL HISTORY OF BONE LOSS IN MEN WITH PROSTATE CANCER RECEIVING ANDROGEN-DEPRIVATION THERAPY
    Saad, Fred
    Feldman, Robert
    Heracek, Jiri
    Ke, Chunlei
    Goessi, Carsten
    JOURNAL OF UROLOGY, 2009, 181 (04): : 593 - 594
  • [48] Axial vs peripheral bone mineral density changes after initiation of androgen deprivation therapy in men with prostate cancer
    ElMiedany, Y.
    Gardiner, A.
    Dickinson, I.
    Toth, M.
    RHEUMATOLOGY, 2007, 46 : I126 - I127
  • [49] Resistance exercise in men receiving androgen deprivation therapy for prostate cancer
    Segal, RJ
    Reid, RD
    Courneya, KS
    Malone, SC
    Parliament, MB
    Scott, CG
    Venner, PM
    Quinney, HA
    Jones, LW
    D'Angelo, MES
    Wells, GA
    JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (09) : 1653 - 1659
  • [50] Differing Effects of Zoledronic Acid on Bone Microarchitecture and Bone Mineral Density in Men Receiving Androgen Deprivation Therapy: A Randomized Controlled Trial
    Cheung, Ada S.
    Hoermann, Rudolf
    Ghasem-Zadeh, Ali
    Tinson, Alistair J.
    Ly, Vivian
    Milevski, Stefan, V
    Joon, Daryl Lim
    Zajac, Jeffrey D.
    Seeman, Ego
    Grossmann, Mathis
    JOURNAL OF BONE AND MINERAL RESEARCH, 2020, 35 (10) : 1871 - 1880
12345